Vancomycin capped with silver nanoparticles as an antibacterial agent against multi-drug resistance bacteria

Advanced Pharmaceutical Bulletin

Volumn 7, Issue 3, 2017, Pages 479-483

  Esmaeillou, Mahsa ^a   Zarrini, Gholamreza ^a   Rezaee, Mohammad Ahangarzadeh ^b   Mojarrad, Javid Shahbazi ^b   Bahadori, Ali ^c  

^a UNIVERSITY OF TABRIZ   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Sarab Faculty of Medical Sciences   (Iran)

Author keywords

Antibacterial agent; Multi drug resistance bacteria; Silver nanoparticles; Vancomycin

Indexed keywords

N HYDROXYSUCCINIMIDE; SILVER NANOPARTICLE; THIOGLYCOLIC ACID; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG FORMULATION; DRUG SCREENING; DRUG STRUCTURE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NANOANALYSIS; NANOFABRICATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 85030115718     PISSN: 22285881     EISSN: 22517308     Source Type: Journal    
DOI: 10.15171/apb.2017.058     Document Type: Article

References (12)

1. Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365(9459):579-87. doi: 10.1016/S0140-6736(05)17907-0
2. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez JT, et al. The bactericidal effect of silver nanoparticles. Nanotechnology 2005;16(10):2346-53. doi: 10.1088/0957-4484/16/10/059
3. Griffith RS. Vancomycin use an historical review. J Antimicrob Chemother 1984;14(suppl D):1-5
4. Dalla Costa LM, Reynolds PE, Souza HA, Souza DC, Palepou MF, Woodford N. Characterization of a divergent vand-type resistance element from the first glycopeptide-resistant strain of enterococcus faecium isolated in brazil. Antimicrob Agents Chemother 2000;44(12):3444-6
5. Thaxton Shad C, Haley Hill D, Georganopoulou DG, Stoeva SI, Mirkin CA. A bio-bar-code assay based upon dithiothreitol-induced oligonucleotide release. Anal Chem 2005;77(24),8174-8. doi: 10.1021/ac0514265
6. Banoee M, Seif S, Nazari ZE, Jafari-Fesharaki P, Shahverdi HR, Moballegh A, et al. Zno nanoparticles enhanced antibacterial activity of ciprofloxacin against staphylococcus aureus and escherichia coli. J Biomed Mater Res B Appl Biomater 2010;93(2):557-61. doi: 10.1002/jbm.b.31615
7. Wang S, Mamedova N, Kotov NA, Chen W, Studer J. Antigen/antibody immunocomplex from CdTe nanoparticle bioconjugates. Nano Lett 2002;2(8),817-22. doi: 10.1021/nl0255193
8. Mock JJ, Barbic M, Smith DR, Schultz DA, Schultz S. Shape effects in plasmon resonance of individual colloidal silver nanoparticles. J Chem Phys 2002;116(15):6755-9. doi: 10.1063/1.1462610
9. Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against staphylococcus aureus and escherichia coli. Nanomedicine 2007;3(2):168-71. doi: 10.1016/j.nano.2007.02.001
10. Huang L, Dai T, Xuan Y, Tegos GP, Hamblin MR. Synergistic combination of chitosan acetate with nanoparticle silver as a topical antimicrobial: Efficacy against bacterial burn infections. Antimicrob Agents Chemother 2011;55(7):3432-8. doi: 10.1128/AAC.01803-10
11. Wei Q, Ji J, Fu J, Shen J. Norvancomycin-capped silver nanoparticles: synthesis and antibacterial activities against E. coli. Sci China Chem 2007;50(3),418-24. doi: 10.1007/s11426-007-0028-6
12. Gu H, Ho PL, Tong E, Wang L, Xu B. Presenting vancomycin on nanoparticles to enhance antimicrobial activities. Nano Lett 2003; 3(9):1261-3. doi: 10.1021/nl034396z